Inspirna
New York, US · 9 known investors
Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform. The company focuses on common cancers with high unmet need through small molecules and biologics.
Founders & leadership
ST
Sohail TavazoieCo-Founder & Chair of Scientific Advisory Board
MT
Masoud TavazoieinCo-Founder & Advisor
Investors · 9
Sofinnova Partners✓ verifiedParis · $540K – $27M
Vivo Capital✓ verifiedPalo Alto · $10M – $50M
Sands Capital Ventures✓ verifiedArlington · $10M – $30M
Start Capital
Novo Holdingsreported · 2 sourcesCopenhagen · $1.1M – $54M
Also in the syndicate · 4
Dreavent 6Lepu HoldingsNew York City Investment Fund LLCSixty Degree Capital Fund
Funding
SEC filings, press & company announcements$50M disclosed across 1 of 2 rounds · 2022
- $50MSeries DJul 2022 · 3 sources
Sands Capital (lead), Vivo Capital (lead), Dreavent 6, Lepu Holdings, New York City Investment Fund LLC, Novo Holdings A/S, Sixty Degree Capital Fund, Sofinnova Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Inspirna do?
- Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform. The company focuses on common cancers with high unmet need through small molecules and biologics.
- Who founded Inspirna?
- Inspirna was founded by Sohail Tavazoie, Masoud Tavazoie.
- Who are Inspirna's investors?
- Inspirna's investors include Sofinnova Partners, Vivo Capital, Sands Capital Ventures, Start Capital, Novo Holdings.
- How much funding has Inspirna raised?
- Inspirna has disclosed $50M raised across 1 of its 2 known rounds.
- Where is Inspirna headquartered?
- Inspirna is headquartered in New York, US.